Prospective association between lipid soluble antioxidants and coronary heart disease in men. The multiple risk factor intervention trial

American Journal of Epidemiology

Volumn 147, Issue 2, 1998, Pages 180-186

  Evans, Rhobert W ^a   Jessica Shaten, B ^b   Day, Billy W ^a   Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Carotenoids; Coronary disease; Prospective studies; Retinol; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CAROTENOID; GAMMA TOCOPHEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR;

EID: 2642679249     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009432     Document Type: Article

References (44)

1. Manson JE, Gaziano JM, Jonas MA, et al. Antioxidants and cardiovascular disease: a review. J Am Coll Nutr 1993;12:426-32.
2. Burton GW, Ingold KU. β-Carotene: an unusual type of lipid antioxidant. Science 1984;224:569-73.
3. Palozza P, Luberto C, Calviello G, et al. Antioxidant and prooxidant role of β-carotene in murine normal and tumor thymocytes: effects of oxygen partial pressure. Free Rad Biol Med 1997;22:1065-73.
4. Ingold KU, Bowry VW, Stocker R, et al. Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc Natl Acad Sci USA 1993;90:45-9.
5. Esterbauer H, Gebicki J, Puhl H, et al. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-90.
6. Olson JA. Biological actions of carotenoids. J Nutr 1989;119:94-5.
7. Parker RS. Dietary and biochemical aspects of vitamin E. Adv Food Nutr Res 1989;33:157-232.
8. Brown ED, Micozzi M, Craft N, et al. Plasma carotenoid and retinol concentrations in healthy young males. (Abstract). Fed Proc 1986;45:592.
9. Grisham MB, McCord JM. Chemistry and cytoxicity of reactive oxygen metabolites. In: Taylor AE, Matalon S, Ward PA, eds. Physiology of oxygen radicals. Baltimore, MD: Waverly Press, Inc, 1986:1-18.
10. Machlin LJ. Vitamin E. In: Machlin LJ, ed. Handbook of vitamins. 2nd ed. New York: Marcel Dekker, Inc, 1991:99-144.
11. Olson JA. Vitamin A. In: Machlin LJ, ed. Handbook of vitamins. 2nd ed. New York: Marcel Dekker, Inc, 1991:1-58.
12. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982;248:1465-77.
13. Driskell WJ, Neese JW, Bryant CC, et al. Measurement of vitamin A and vitamin E in human serum by high-performance liquid chromatography. J Chromatogr 1982;231:439-44.
14. Miller KW, Lorr NA, Yang CS. Simultaneous determination of plasma retinol, alpha-tocopherol, lycopene, alpha-carotene, and beta carotene by high performance liquid chromatography. Anal Biochem 1984;138:340-5.
15. Cooper GR, Haff AC, Widdowson GM, et al. Quality control in the MRFIT Local Screening and Clinic Laboratory. Control Clin Trials 1986;7:158S-165S.
16. Caggiula AW, Christakis G, Farrand M, et al. The Multiple Risk Factor Intervention Trial (MRFIT). IV. Intervention on blood lipids. Prev Med 1981;10:443-75.
17. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
18. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34:187-202.
19. Comstock GW, Alberg AJ, Helzlsouer KJ. Reported effects of long-term freezer storage on concentrations of retinol, β-carotene and α-tocopherol in serum or plasma summarized. Clin Chem 1993;39:1075-8.
20. Zondervan KT, Ocke MC, Smit HA, et al. Do dietary and supplementary intake of antioxidants differ with smoking status? Int J Epidemiol 1996;25:70-9.
21. Acheson RM, Williams DRR. Does consumption of fruit and vegetables protect against stroke? Lancet 1983;1:1191-3.
22. Gaziano JM, Manson JE, Branch LG, et al. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 1995;5:255-60.
23. Gey KF, Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann NY Acad Sci 1989;570:268-82.
24. Riemersma RA, Oliver M, Elton RA, et al. Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. Eur J Clin Nutr 1990;44:143-50.
25. Dimitrov MV, Meyer C, Gilliland D, et al. Plasma tocopherol concentrations in response to supplemental vitamin E. Am J Clin Nutr 1991;53:723-9.
26. Traber MG, Carpentier YA, Kayden HJ, et al. Alterations in plasma α- and γ-tocopherol concentrations in response to intravenous infusion of lipid emulsions in humans. Metabolism 1993;42:701-9.
27. Riemersma RA, Wood DA, Macintyre CCA, et al. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E, and carotene. Lancet 1991;337:1-5.
28. Kardinaal AFM, Kok FJ, Ringstad J, et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993;342:1279-84.
29. Street DA, Comstock GW, Salkeld RM, et al. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction? Circulation 1994;90:1154-61.
30. Kok FJ, de Bruijn M, Vermeeren R, et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462-8.
31. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985;56:226-31.
32. Salonen JT, Salonen R, Seppanen K, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischemic heart disease in Eastern Finnish men. Atherosclerosis 1988;70:155-60.
33. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9.
34. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
35. Eicholzer M, Stahelin HB, Gey KF. Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease, and stroke, respectively: 12-year follow-up of the Prospective Basel Study. In: Emenent I, Chance B, eds. Free radicals and aging. Basel, Switzerland: Burkhauser Verlag, 1992:398-410.
36. Gaziano JM, Manson JE, Ridker PM, et al. Beta carotene therapy for chronic stable angina. (Abstract). Circulation 1990;82-III:201.
37. Haeger K. Long-time treatment of intermittent claudication with vitamin E. Am J Clin Nutr 1974;27:1179-81.
38. DeMaio SJ, King SB, Lembo NJ, et al. Vitamin E supplementation, plasma lipids, and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr 1992;11:68-73.
39. Gillilan RE, Mondell B, Warbasse JR. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J 1977;93:444-9.
40. Greenberg ER, Baron JA, Karagas MR, et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 1996;275:699-703.
41. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/ mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92.
42. Heinonen OP, Albanes D. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
43. Rapola JM, Virtamo J, Haukka JK, et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris. JAMA 1996;275:693-8.
44. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.